Archive for Январь, 2007
Dr. Steve Bloom, researcher at Imperial College in London
Here are some of the things being said about Acomplia by doctors. Keep in mind that some of these may have an interest in the clinical trials underway sponsored by Sanofi-Aventis.
"If there was a pill available that was safe, effective and made it easy to lose any weight at all, [...]
New “News” — Well, Not Exactly — About Benefits of Acomplia
A new report in the prestigious New Acomplia (rimonabant) England Journal of Medicine has focused renewed attention on one of the earlier studies of Acomplia (rimonabant) — originally reported on in March 2004 — which found that overweight or obese patients with untreated dyslipidemia (high triglycerides, low HDL-cholesterol) lost [...]
New Acomplia Study Has More Good News for Obese Diabetics
The latest results of the last of four major Acomplia (rimonabant) studies added more good news to the mounting excitement about this breakthrough obesity drug.
Not only does Acomplia help obese people Acomplia (rimonabant) lose weight, raise their good cholesterol, lower their triglicerides, and [...]
FDA: 30 Percent of U.S. Patients on Diet Drugs Also Take Antidepressants
While Sanofi-Aventis says patients on antidepressants should not take diet–drug rimonabant Acomplia (rimonabant) ), the FDA says data it obtained for 2004-2006 showed that 30 percent of the 580,000 patients prescribed diet pills each year received a concurrent prescription for an antidepressant drug.
The fact that [...]
New Clinical Trial Results for Acomplia to Be Presented November 9th
Optimism about prospects for the new diet drug rimonabant (Acomplia) surged on the news that manufacturer Sanofi-Aventis plans to present data from two years of clinical trials, rather than one-year data, at the annual scientific meeting of the American Heart Association on November 9th in New Orleans.
One-year [...]
Sanofi Agrees Not to Interfere With News Site
Medical Week News, Inc., publisher of the news website http://pythontail.org, announced it has withdrawn its lawsuit against French pharmaceutical giant Sanofi-Aventis Acomplia (rimonabant) Group after an agreement was reached under which Sanofi will not interfere with publication of the internet newsletter.
The website, which has become the most comprehensive source of [...]
